AMPH Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (1 Jul 2024 @ 16:00):
Our systems believe the stock currently is undervalued by 0.51% compare to its pairs and should correct upwards.

Stats
Today's Volume	713 338
Average Volume	345 017
Market Cap	1.88B
EPS	$0.900 ( Q1 \| 2024-05-10 )
Next earnings date	( $0 ) 2024-08-06
Last Dividend	$0.300 ( 2010-06-11 )
Next Dividend	$0 ( N/A )
P/E	13.23 (Sector) 42.63 (Industry) 0
ATR14	$0.0530 (0.14%)

ACOR -24.02%

ACRX 7.50%

ADMP 0.85%

ADMS 0.00%

AGRX 0.71%

AKAN -2.16%

ALIM -0.72%

AMPH -3.73%

AMYT 0.00%

ANIP -0.38%

AQST -5.77%

ASRT -4.03%

ATNX 0.00%

AVDL 0.43%

AYTU -2.06%

BFRI -0.67%

BGXX 8.76%

CLVR -1.52%

COLL 1.30%

CPIX -3.27%

CRDL -0.99%

CRON -1.29%

CYTH -5.51%

DCPH 0.00%

DERM -4.79%

DRRX 1.55%

DVAX -0.62%

EGRX -1.25%

EMBC -2.80%

EMBCV -9.33%

EOLS 2.12%

ESPR 5.41%

EVOK -10.81%

FLGC -2.94%

FLXN 0.00%

GHSI -2.08%

HCM 2.57%

HROW 0.77%

HUGE -14.49%

IMCC -3.43%

INCR 1.00%

IRWD 0.00%

ITCI -0.73%

IXHL 0.34%

JUPW 11.76%

KALA -2.82%

KIN 0.11%

KMDA -3.40%

LNTH -0.36%

NBIX 1.77%

NEPT 0.00%

NLTX 1.45%

OGI 0.00%

OPTN 0.96%

ORGO -3.57%

PAHC 1.61%

PCRX -0.52%

PETQ 3.67%

PLXP 0.00%

PPD 0.00%

PROC 3.16%

PRPH -2.87%

PTPI -5.66%

RDHL -2.00%

RDUS 0.13%

REPH -0.48%

RGC -5.03%

RMTI -5.11%

SCTL 0.92%

SCYX -2.50%

SIGA -0.53%

SISI -14.23%

SNDL 1.05%

SNOA 8.44%

SSIC -2.37%

SUPN -0.75%

SXTC -2.79%

THTX -1.41%

TKNO -11.68%

TLGT -13.85%

TLRY 1.20%

TXMD 6.21%

TYHT -3.90%

UPC 2.08%

VTRS -0.38%

ZYNE 2.36%

Insider Trading

Date	Person	Action	Amount	type
2024-06-27	Peters William J	Sell	2 961	Common Stock
2024-06-27	Peters William J	Sell	635	Common Stock
2024-06-10	Zhang Jack Y.	Buy	100 000	Common Stock
2024-06-10	Zhang Jack Y.	Sell	100 000	Employee Stock Option (right to buy)
2024-06-10	Petersen Floyd F.	Sell	3 000	Common Stock

INSIDER POWER
1.38
Last 100 transactions
Buy: 1 624 832 \| Sell: 1 632 860

Correlation (AI algo v.1.1b): Undervalued: 0.51% $38.71 paired level. (The Algo Track The Changes Of The Most Correlated Stocks In Realtime And Give An Instant Update)

Volume Correlation

Long: -0.03 (neutral)

Short: 0.39 (neutral)

Signal:(39.716) Neutral

Amphastar Pharmaceuticals Correlation

10 Most Positive Correlations
AGRX	0.955
AUUD	0.951
RRGB	0.951
SMSI	0.95
QNRX	0.945
LPSN	0.943
COMM	0.942
XMTR	0.94
RIVN	0.939
RDUS	0.936

10 Most Negative Correlations
OZEM	-1
BWIN	-0.951
SHLD	-0.933
CDRO	-0.931
RNA	-0.926
DXJS	-0.924
ROOT	-0.92
ARYD	-0.92
FANG	-0.92
EQRR	-0.919

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Amphastar Pharmaceuticals Correlation - Currency/Commodity

-0.46
( neutral )

-0.30
( neutral )

0.00
( neutral )

-0.34
( neutral )

0.00
( neutral )

0.46
( neutral )

Amphastar Pharmaceuticals Financials

Annual	2023
Revenue:	$644.40M
Gross Profit:	$343.97M (53.38 %)
EPS:	$2.85

FY	2023
Revenue:	$644.40M
Gross Profit:	$343.97M (53.38 %)
EPS:	$2.85

FY	2022
Revenue:	$498.99M
Gross Profit:	$248.86M (49.87 %)
EPS:	$1.880

FY	2021
Revenue:	$437.77M
Gross Profit:	$199.74M (45.63 %)
EPS:	$1.350

Financial Reports:

No articles found.

Amphastar Pharmaceuticals Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Amphastar Pharmaceuticals Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 9.75 - good (97.49%) | Divividend Growth Potential Score: 5.40 - Potential for dividend initiation, but uncertain (8.01%)

Information

First Dividend	$0.300	2009-06-11
Last Dividend	$0.300	2010-06-11
Next Dividend	$0	N/A
Payout Date	2010-06-30
Next Payout Date	N/A
# dividends	2	--
Total Paid Out	$0.600	--
Avg. Dividend % Per Year	0.00%	--
Score	2.79	--
Div. Sustainability Score	9.75
Div.Growth Potential Score	5.40
Div. Directional Score	7.58	--

Next Divdend (Est)
(2025-03-28)

$0 Estimate 0.00 %

Dividend Stability

0.01 Very Bad

Dividend Score

2.79

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2009	$0	0.00%
2010	$0	0.00%
2011	$0	0.00%
2012	$0	0.00%
2013	$0	0.00%
2014	$0	0.00%
2015	$0	0.00%
2016	$0	0.00%
2017	$0	0.00%
2018	$0	0.00%
2019	$0	0.00%
2020	$0	0.00%
2021	$0	0.00%
2022	$0	0.00%
2023	$0	0.00%
2024	$0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Dividend History

Ex Date	Amount	Declaration Date	Record Date	Payment Date
11 Jun 2010	$0.300	07 Jun 2010	30 Nov -0001	30 Jun 2010
11 Jun 2009	$0.300	05 Jun 2009	30 Nov -0001	30 Jun 2009

Top 10 dividend Companies for NASDAQ

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
OXLC	Dividend Diamond	2024-09-16	Monthly	14	15.03%	9.60
DMLP	Dividend Diamond	2024-04-26	Quarterly	22	10.71%	9.35
OXSQ	Dividend Diamond	2024-09-16	Monthly	21	12.73%	9.02
ARLP	Dividend Royal	2024-05-07	Quarterly	26	9.67%	8.87
PNNT	Dividend Royal	2024-06-14	Monthly	18	9.49%	8.82
MFIC	Dividend Royal	2024-06-11	Quarterly	21	10.89%	8.79
SPOK	Dividend Royal	2024-05-23	Quarterly	20	8.73%	8.72
PSEC	Dividend Royal	2024-06-25	Monthly	21	9.03%	8.65
SBLK	Dividend Royal	2024-06-06	Quarterly	17	13.10%	8.63
GBDC	Dividend Royal	2024-11-29	Bi-Monthly	15	8.53%	8.62

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.229	1.500	5.42	8.14	[0 - 0.5]
returnOnAssetsTTM	0.0983	1.200	6.72	8.07	[0 - 0.3]
returnOnEquityTTM	0.248	1.500	8.36	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	2.18	0.800	4.12	3.30	[1 - 3]
quickRatioTTM	1.686	0.800	4.79	3.83	[0.8 - 2.5]
cashRatioTTM	0.789	1.500	6.73	10.00	[0.2 - 2]
debtRatioTTM	0.380	-1.500	3.67	-5.50	[0 - 0.6]
interestCoverageTTM	19.33	1.000	3.95	3.95	[3 - 30]
operatingCashFlowPerShareTTM	4.12	2.00	8.63	10.00	[0 - 30]
freeCashFlowPerShareTTM	3.34	2.00	8.33	10.00	[0 - 20]
debtEquityRatioTTM	0.890	-1.500	6.44	-9.66	[0 - 2.5]
grossProfitMarginTTM	0.535	1.000	4.41	4.41	[0.2 - 0.8]
operatingProfitMarginTTM	0.313	1.000	5.74	5.74	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.332	1.000	9.27	9.27	[0.2 - 2]
assetTurnoverTTM	0.430	0.800	-0.470	-0.376	[0.5 - 2]
Total Score				9.75

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	12.47	1.000	8.84	0	[1 - 100]
returnOnEquityTTM	0.248	2.50	8.94	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	3.34	2.00	8.89	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	4.12	2.00	8.63	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.649	1.500	9.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.293	1.000	5.16	0	[0.1 - 0.5]
Total Score				5.40

Amphastar Pharmaceuticals Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Amphastar Pharmaceuticals

Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin, a low molecular weight heparin to prevent and treat deep vein thrombosis; Naloxone for opioid overdose; Glucagon for injection emergency kit; and Cortrosyn, a lyophilized powder for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency. The company also provides Amphadase, a bovine-sourced hyaluronidase injection to absorb and disperse other injected drugs; Epinephrine injection for the emergency treatment of allergic reactions; lidocaine jelly, an anesthetic product for urological procedures; lidocaine topical solution for various procedures; phytonadione injection, a vitamin K1 injection for newborn babies; emergency syringe products for emergency use in hospital settings; morphine injection for use with patient controlled analgesia pumps; and lorazepam injection for surgery and medical procedures. In addition, it offers neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; and Isoproterenol hydrochloride injection for mild or transient episodes of heart block. Further, the company distributes recombinant human insulin active pharmaceutical ingredients (API) and porcine insulin API. It serves hospitals, care facilities, alternate care sites, clinics, and doctors' offices. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California.